Sir Desmond, a retired racing Greyhound, is the latest beneficiary
|
There are many reasons why development of immunotherapies in dogs has been slow
|
The companies will combine their assets to help advance research in both animal and human medicine
|
It’s no secret that dogs can identify several types of cancers, including prostrate, breast, colon, and lung
|
The online resource features some of the veterinary community’s leading nutrition experts
|
Three veterinary oncology centers discuss imaging equipment, promising research, and what the future holds
|
November is National Pet Cancer Awareness Month, a time designated to educate people on the common disease in animals
|
Team with clients to ensure optimal calorie intake and nourishing sustenance during treatment
|
Experimental cancer immunotherapy seeks to provide alternatives to surgery
|
Cancer is not a reportable disease in pets
|
The company, which provides personalized cancer immunotherapies to the veterinary market, was honored with a check for $10,000
|
A new surgical procedure involves a nanoparticle compound and cancer cell illumination
|
CIV, cancer, osteosarcoma, valley fever vaccines updates
|
CETCOR focuses on improving the diagnosis, management, and treatment of both human and animal cancers
|
Targeting non-invasive veterinary cancer diagnostic assay
|
The pet insurer will donate $5 to the Animal Cancer Foundation up to $50,000 for every photo, story, or statistic shared on Facebook, Twitter, and Instagram using #CurePetCancer
|
Goals include Improving coordination between collaborative groups that organize clinical trials in pets and in people
|
|
|
